| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
169,410,000 |
| Market
Cap: |
97.83(M) |
| Last
Volume: |
3,856,623 |
Avg
Vol: |
3,845,860 |
| 52
Week Range: |
$0.35 - $0.885 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
5,700 |
49,676 |
| Total Sell Value |
$0 |
$0 |
$3,192 |
$85,601 |
| Total People Sold |
0 |
0 |
1 |
3 |
| Total Sell Transactions |
0 |
0 |
1 |
7 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kies Peter |
CFO |
• – – |
2020-03-05 |
4 |
D |
$9.80 |
$96,207 |
D/D |
(9,817) |
126,880 |
|
- |
|
| Kies Peter |
CFO |
• – – |
2020-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,567 |
136,697 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2020-03-05 |
4 |
D |
$9.80 |
$366,236 |
D/D |
(37,371) |
1,183,436 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2020-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
120,100 |
1,220,807 |
|
- |
|
| Weiner David B. |
Director |
– • – |
2020-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,667 |
808,777 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2020-01-13 |
4 |
B |
$3.11 |
$69,975 |
D/D |
22,500 |
1,100,707 |
2.81 |
330% |
|
| Zoth Lota S |
Director |
– • – |
2020-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
4,090 |
|
- |
|
| Yarno Wendy L |
Director |
– • – |
2019-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
16,350 |
|
- |
|
| Humeau Laurent |
Chief Scientific Officer |
• – – |
2019-08-30 |
4 |
B |
$2.22 |
$9,990 |
D/D |
4,500 |
50,333 |
2.74 |
- |
|
| Weiner David B. |
Director |
– • – |
2019-08-01 |
4 |
AS |
$2.72 |
$44,477 |
D/D |
(16,352) |
797,110 |
|
- |
|
| Humeau Laurent |
Chief Scientific Officer |
• – – |
2019-06-05 |
4 |
B |
$2.50 |
$50,000 |
D/D |
20,000 |
45,833 |
2.74 |
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-06-03 |
4 |
S |
$2.31 |
$684,736 |
I/I |
(296,705) |
816,527 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-06-03 |
4 |
S |
$2.30 |
$1,914,468 |
D/D |
(832,848) |
1,078,207 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-05-31 |
4 |
S |
$2.40 |
$1,200,800 |
I/I |
(500,000) |
1,113,232 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-05-31 |
4 |
S |
$2.44 |
$1,217,650 |
D/D |
(500,000) |
1,911,055 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-05-21 |
4 |
S |
$3.31 |
$331,000 |
D/D |
(100,000) |
2,411,055 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-05-16 |
4 |
AS |
$3.50 |
$214,242 |
I/I |
(61,212) |
1,613,232 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • – |
2019-05-15 |
4 |
AS |
$3.50 |
$264,446 |
I/I |
(75,556) |
1,674,444 |
|
- |
|
| Cabrera Angel |
Director |
– • – |
2019-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,170 |
67,589 |
|
- |
|
| Benito Simon X |
Director |
– • – |
2019-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,170 |
43,637 |
|
- |
|
| Yarno Wendy L |
Director |
– • – |
2019-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,170 |
12,260 |
|
- |
|
| Collins Morton |
Director |
– • – |
2019-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,170 |
168,130 |
|
- |
|
| Weiner David B. |
Director |
– • – |
2019-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,170 |
813,462 |
|
- |
|
| Weiner David B. |
Director |
– • – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,667 |
805,292 |
|
- |
|
| Kies Peter |
CFO |
• – – |
2019-03-10 |
4 |
D |
$3.34 |
$23,600 |
D/D |
(7,066) |
109,130 |
|
- |
|
488 Records found
|
|
Page 9 of 20 |
|
|
